Prophylactic intranasal administration of a TLR2 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Epidemiology

Engineering

Medicine

Immunology

Show all topics

DOI

10.1101/2020.09.25.309914

License

cc-no